BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37847609)

  • 1. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
    Tumoglu B; Keelaghan A; Avci FY
    Glycobiology; 2023 Dec; 33(11):879-887. PubMed ID: 37847609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen.
    Gabba A; Bogucka A; Luz JG; Diniz A; Coelho H; Corzana F; Cañada FJ; Marcelo F; Murphy PV; Birrane G
    Biochemistry; 2021 May; 60(17):1327-1336. PubMed ID: 33724805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
    da Costa V; van Vliet SJ; Carasi P; Frigerio S; García PA; Croci DO; Festari MF; Costa M; Landeira M; Rodríguez-Zraquia SA; Cagnoni AJ; Cutine AM; Rabinovich GA; Osinaga E; Mariño KV; Freire T
    Cancer Lett; 2021 Oct; 518():72-81. PubMed ID: 34144098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System.
    Szczykutowicz J
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).
    van Vliet SJ; Vuist IM; Lenos K; Tefsen B; Kalay H; García-Vallejo JJ; van Kooyk Y
    J Biol Chem; 2013 Sep; 288(38):27519-27532. PubMed ID: 23918927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.
    Marcelo F; Supekar N; Corzana F; van der Horst JC; Vuist IM; Live D; Boons GPH; Smith DF; van Vliet SJ
    J Biol Chem; 2019 Jan; 294(4):1300-1311. PubMed ID: 30504228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
    Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
    J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGL Receptor and Immunity: When the Ligand Can Make the Difference.
    Zizzari IG; Napoletano C; Battisti F; Rahimi H; Caponnetto S; Pierelli L; Nuti M; Rughetti A
    J Immunol Res; 2015; 2015():450695. PubMed ID: 26839900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines.
    Pirro M; Rombouts Y; Stella A; Neyrolles O; Burlet-Schiltz O; van Vliet SJ; de Ru AH; Mohammed Y; Wuhrer M; van Veelen PA; Hensbergen PJ
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129513. PubMed ID: 31911241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
    Zaal A; Li RJE; Lübbers J; Bruijns SCM; Kalay H; van Kooyk Y; van Vliet SJ
    Front Immunol; 2020; 11():305. PubMed ID: 32161592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Tn-Antigen-Positive Human Tumors with a Recombinant Human Macrophage Galactose C-Type Lectin.
    Bulteau F; Thépaut M; Henry M; Hurbin A; Vanwonterghem L; Vivès C; Le Roy A; Ebel C; Renaudet O; Fieschi F; Coll JL
    Mol Pharm; 2022 Jan; 19(1):235-245. PubMed ID: 34927439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells.
    Pirro M; Schoof E; van Vliet SJ; Rombouts Y; Stella A; de Ru A; Mohammed Y; Wuhrer M; van Veelen PA; Hensbergen PJ
    J Proteome Res; 2019 Mar; 18(3):1125-1132. PubMed ID: 30582698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties.
    Costa VD; Mariño KV; Rodríguez-Zraquia SA; Festari MF; Lores P; Costa M; Landeira M; Rabinovich GA; van Vliet SJ; Freire T
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
    Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
    Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL).
    Mortezai N; Behnken HN; Kurze AK; Ludewig P; Buck F; Meyer B; Wagener C
    Glycobiology; 2013 Jul; 23(7):844-52. PubMed ID: 23507963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose-Type Lectin.
    Diniz A; Coelho H; Dias JS; van Vliet SJ; Jiménez-Barbero J; Corzana F; Cabrita EJ; Marcelo F
    Chemistry; 2019 Nov; 25(61):13945-13955. PubMed ID: 31404475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.